Navigation Sciences Inc. has enrolled the initial patient in the first-in-human clinical feasibility trial of the Navisci system designed for surgeons to be able to remove probable early-stage lung tumors in minimally invasive surgery, integrating augmented reality (AR) and advanced software with surgical instruments.